Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PulteGroup | PHM | Sep 19, 2024 | 144.98 | +2.83 |
Puma Biotechnology | PBYI | Sep 19, 2024 | 2.56 | +2.40 |
Pure Cycle | PCYO | Sep 19, 2024 | 11.23 | +4.71 |
Pure Storage A | PSTG | Sep 19, 2024 | 49.75 | +0.95 |
PureCycle Technologies | PCT | Sep 19, 2024 | 9.28 | +13.87 |
PureCycle Technologies Unit | PCTTU | Sep 19, 2024 | 10.45 | +4.50 |
Purefunds ISE Junior Silver [Sm | SILJ | Sep 19, 2024 | 12.69 | +2.09 |
PureTech Health ADR | PRTC | Sep 19, 2024 | 19.43 | +0.08 |
Purple Biotech ADR | PPBT | Sep 19, 2024 | 6.98 | -1.69 |
Purple Innovation | PRPL | Sep 19, 2024 | 1.07 | +1.90 |
Putnam Managed Municipal Income Trust | PMM | Sep 19, 2024 | 6.56 | +0.15 |
Putnam Master Intermediate Income Trust | PIM | Sep 19, 2024 | 3.40 | -0.73 |
Putnam Municipal Opportunities Trust | PMO | Sep 19, 2024 | 10.76 | -0.19 |
Putnam Premier Income Trust | PPT | Sep 19, 2024 | 3.71 | -0.54 |
PVH | PVH | Sep 19, 2024 | 97.55 | +1.30 |
Pyrophyte Acquisition | PHYT | Sep 19, 2024 | 11.51 | 0.00 |
Pyxis Oncology | PYXS | Sep 19, 2024 | 3.68 | +0.55 |
Pyxis Tankers | PXS | Sep 19, 2024 | 5.02 | +0.30 |
Pyxis Tankers Pref | PXSAP | Sep 19, 2024 | 25.02 | +0.04 |
Q2 | QTWO | Sep 19, 2024 | 79.73 | +4.81 |
Q32 Bio | QTTB | Sep 19, 2024 | 47.17 | +1.66 |
QCR | QCRH | Sep 19, 2024 | 77.97 | +3.50 |
QIAGEN | QGEN | Sep 19, 2024 | 45.59 | -0.20 |
Qifu Technology ADR | QFIN | Sep 19, 2024 | 26.14 | +4.60 |
Qilian International | QLI | Sep 19, 2024 | 5.41 | 0.00 |
Qilian International | BGM | Sep 19, 2024 | 8.08 | 0.00 |
QMMM | QMMM | Sep 19, 2024 | 5.63 | 0.00 |
Qomolangma Acquisition | QOMO | Sep 19, 2024 | 11.88 | -0.59 |
Qorvo | QRVO | Sep 19, 2024 | 103.17 | +3.38 |
QT Imaging | QTI | Sep 19, 2024 | 0.60 | +1.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.